Together our data demonstrate that the PI3K p110α and PI3K p110β isoforms appear to differentially contribute to critical cell responses in GBM, which is important when considering the future use of isoform-specific PI3K inhibitors. This evidence concerns the gene PIK3CA and glioblastoma.